Skip to content

Study · Not a test of the peptide alone · 2010

1 result

Thymosin alpha1 injection-type subcutaneous implant

YANQIANG ZHONG, QINGFENG LIU, YING LU, HAO ZOU, ZHIGUO SUN, GUOQING ZHANG, JING GAO, YUAN YU, YAN CHEN, HE ZHANG, JINHUA MA, RUNCHEN ZHOU, JIMING XUAN, WEI ZHONG

Journal not recorded8 Sept 2009

PepBankPUB-95204026
Source linkAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone1

In this study, Thymosin alpha-1 was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Thymosin alpha-1.

  1. 01LabNot a test of Thymosin alpha-1 aloneOther designPharmacokinetics

    A PLGA-based injection-type Talpha1 implant showed sustained release over 28 days with accumulative release above 90%.

    In plain wordsIn lab release tests, a thymosin alpha‑1 implant released the peptide steadily for 28 days, with over 90% released.

    Peptide
    Thymosin alpha-1
    Outcome
    Not applicableIn vitro release from the subcutaneous implant
    Study

    n: not reported in source

    In-vitro drug-release device
    Outcome group
    Pharmacokinetics · Pharmacology

    Source sentences

    Summary
    T alpha1 has the sustained-release effect for 28 days with the accumulative release being higher than 90%

    In this study, Thymosin alpha-1 was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymosin alpha-1.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 3Current

    10 Oct 2026, 08:55 UTC

    Study results updated

  2. Version 2

    9 Oct 2026, 03:03 UTC

    Study data updated · source update from Europe PMC

  3. Version 1

    9 Oct 2026, 03:02 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

Publication types

PepBank is a research reference. Talk to a doctor before you use any peptide.